TNF and fibromyalgia: FMS had been recently recognized as one of the main predictors of drug discontinuation in PsA patients on TNF inhibitors (12), with almost no PsA patients with comorbid fibromyalgia achieving clinical disease remission upon anti-TNF therapy (11).